Edition:
United States

Analyst Research: Alexion Pharmaceuticals Inc (ALXN.O)

ALXN.O on Nasdaq

144.89USD
10:17am EDT
Change (% chg)

$4.36 (+3.10%)
Prev Close
$140.53
Open
$141.71
Day's High
$145.00
Day's Low
$141.00
Volume
548,451
Avg. Vol
1,737,034
52-wk High
$208.88
52-wk Low
$124.16

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Alexion Pharmaceuticals, Inc. (ALXN) - Financial and Strategic SWOT Analysis Review 2 May 2016 GlobalData 97 300.00
Trading Report for (ALXN). A detailed report, including free correlated market analysis, and updates. 1 May 2016 Stock Traders Daily 6 20.00
ALXN: Due Diligence Review: Forensic Earnings and Valuation 1 May 2016 New Constructs, LLC 10 25.00
Is The Recovery in Alexion Pharmaceuticals, Inc. Too Much, Too Soon? 1 May 2016 Sadif Analytics Prime 12 25.00
Thomson Reuters Stock Report - Alexion Pharmaceuticals Inc (ALXN-O) 1 May 2016 Thomson Reuters Stock Report 12 25.00
ValuEngine Rating and Forecast Report for ALXN 30 Apr 2016 ValuEngine, Inc. 11 25.00
Alexion Pharmaceuticals 30 Apr 2016 S&P Capital IQ – STARS Reports 10 115.00
ALEXION PHARMACEUTICAL INC (ALXN=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS 29 Apr 2016 Pechala's Reports 2 25.00
Alexion Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 29 Apr 2016 Reuters Investment Profile 12 20.00
Value Graph: ALEXION PHARM -- ALXN 28 Apr 2016 Ford Investor Services, Inc. 1 12.00
 
Name Age Since Current Position

Leonard Bell

57 2015 Chairman of the Board

David Hallal

49 2015 Chief Executive Officer, Director

Vikas Sinha

52 2012 Chief Financial Officer, Executive Vice President

Clare Carmichael

56 2014 Chief Human Resource Officer, Executive Vice President

John Moriarty

48 2014 Executive Vice President, General Counsel
Search Stocks